Protalix BioTherapeutics ...
(PLX)
undefined
undefined%
At close: undefined
1.74
-3.87%
After-hours Dec 13, 2024, 04:17 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 | FY97 | FY96 |
| Net Income | 8.31M | -14.93M | -27.58M | -6.52M | -18.28M | -26.46M | -85.28M | -29.18M | -27.28M | -29.94M | -27.79M | -11.62M | -36.53M | -29.00M | -31.44M | -22.41M | -22.48M | -9.39M | -74.93K | -160.07K | -140.71K | -149.76K | -329.17K | -105.61K | -997.87K | -1.15M | 118.44K | 131.68K |
| Depreciation & Amortization | 1.19M | 1.09M | 1.12M | 1.30M | 1.62M | 1.67M | 1.92M | 1.98M | 2.37M | 3.14M | 3.54M | 3.69M | 3.63M | 3.13M | 1.99M | 1.30M | 759.00K | 502.00K | - | - | - | - | - | - | 163.20K | 202.21K | - | - |
| Stock-Based Compensation | 3.45M | 2.08M | 2.38M | 3.13M | 835.00K | 514.00K | 337.00K | 988.00K | 1.80M | 1.24M | 4.09M | 7.75M | 886.00K | 1.28M | 2.68M | 3.07M | 10.85M | 3.42M | - | - | - | - | - | - | - | - | - | - |
| Other Working Capital | -13.16M | -7.17M | 13.23M | -26.20M | -9.58M | 17.88M | 26.76M | -411.00K | 362.00K | -7.17M | -7.16M | 1.28M | -3.00M | -4.56M | 64.61M | - | - | - | - | - | - | - | - | - | - | - | 10.23K | 79.96K |
| Other Non-Cash Items | -638.00K | -1.23M | 3.09M | 3.64M | 3.37M | 3.07M | 4.57M | 581.00K | 569.00K | 1.89M | -137.00K | -171.00K | -36.37M | 377.00K | 265.00K | 3.05M | 11.10M | 3.57M | - | - | 4.25K | -150 | -66.29K | -141.30K | 508.36K | -526.47K | -343.84K | -243.74K |
| Deferred Income Tax | -3.09M | - | 813.00K | -522.00K | -68.00K | -64.00K | 39.35M | -7.59M | 1.56M | 115.00K | 142.00K | 240.00K | 36.87M | -617.00K | -218.00K | -3.03M | -11.71M | -3.46M | - | - | - | - | - | - | - | - | -32.75K | -8.47K |
| Change in Working Capital | -10.54M | -12.02M | 9.90M | -27.13M | -6.83M | 13.53M | 29.10M | 1.12M | -3.30M | -5.72M | -10.50M | 741.00K | 7.94M | -13.64M | 71.17M | 2.01M | 1.04M | 269.00K | 2.46K | -8.05K | -218 | 3.33K | -393.96K | 193.80K | -1.08M | 561.54K | 10.23K | 79.96K |
| Operating Cash Flow | -1.32M | -25.00M | -10.29M | -26.11M | -19.36M | -7.74M | -9.99M | -32.10M | -24.28M | -29.28M | -30.65M | 635.00K | -23.57M | -38.46M | 44.45M | -16.02M | -10.45M | -5.09M | -72.47K | -168.13K | -136.68K | -146.59K | -789.43K | -53.11K | -1.41M | -909.52K | -247.92K | -40.57K |
| Capital Expenditures | -1.15M | -628.00K | -1.46M | -655.00K | -627.00K | -686.00K | -971.00K | -849.00K | -464.00K | -785.00K | -1.89M | -2.07M | -5.71M | -7.86M | -6.20M | -3.37M | -2.33M | -842.00K | - | - | - | - | - | - | -29.30K | -139.99K | - | - |
| Acquisitions | - | - | 53.00K | - | - | - | 3.00K | 20.00K | 3.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Purchase of Investments | - | -16.00M | -37.84M | -20.00M | - | - | - | - | - | -90.00K | -212.00K | -218.00K | -165.00K | -137.00K | - | - | - | -47.00K | - | - | -552.36K | - | - | -2.40M | -1.06M | -59.39K | - | -6.32M |
| Sales Maturities Of Investments | - | 11.00M | 57.84M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.22M | 2.24M | - | - | - | - |
| Other Investing Acitivies | -15.56M | 593.00K | 327.00K | 703.00K | -256.00K | 95.00K | -148.00K | -118.00K | 39.85M | -126.00K | -212.00K | -218.00K | 2.00K | -137.00K | 21.00K | -330.00K | -103.00K | -91.00K | - | 552.36K | 60.88K | 38.59K | 97.11K | 226.88K | 1.62M | -3.65M | 31.89K | - |
| Investing Cash Flow | -16.71M | -5.04M | 18.92M | -19.95M | -883.00K | -591.00K | -1.12M | -967.00K | 39.39M | -1.00M | -2.10M | -2.29M | -5.87M | -7.99M | -6.17M | -3.70M | -2.44M | -980.00K | - | 552.36K | -491.48K | 38.59K | 1.31M | 71.37K | 532.43K | -3.85M | 31.89K | -6.32M |
| Debt Repayment | - | - | -34.12M | -215.00K | - | -4.75M | -1.42M | 19.68M | - | - | 66.78M | - | - | - | - | - | - | - | -1.00M | 755.00K | - | - | - | -35.00K | -6.30K | -517.03K | - | - |
| Common Stock Repurchased | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -56.00K | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | 712.00K | 2.00K | 46.20M | 472.00K | - | - | - | 14.00K | 534.00K | 46.00K | 112.00K | 1.23M | 277.00K | 501.00K | 293.00K | 5.00K | -104.00K | 341.00K | -6.88M | - | - | - | - | - | - | 6.48M | - | - |
| Financial Cash Flow | 24.67M | 8.24M | 12.08M | 46.47M | - | -4.75M | -1.42M | 19.70M | 6.63M | 46.00K | 66.89M | 26.56M | 20.93M | 501.00K | 293.00K | -51.00K | 58.57M | 16.71M | 494.00K | - | - | - | - | -35.00K | -6.30K | 5.97M | - | 7.05M |
| Net Cash Flow | 6.52M | -21.87M | 20.72M | 473.00K | -20.02M | -13.36M | -12.12M | -13.09M | 21.61M | -31.63M | 34.36M | 25.03M | -8.90M | -45.37M | 38.67M | -19.22M | 46.44M | 10.64M | 421.52K | 384.23K | -628.16K | -108.00K | 524.90K | -16.73K | -882.01K | 1.20M | -216.03K | 687.89K |
| Free Cash Flow | -2.47M | -25.63M | -11.74M | -26.76M | -19.98M | -8.43M | -10.96M | -32.95M | -24.75M | -30.07M | -32.54M | -1.43M | -29.27M | -46.32M | 38.26M | -19.39M | -12.78M | -5.93M | -72.47K | -168.13K | -136.68K | -146.59K | -789.43K | -53.11K | -1.44M | -1.05M | -247.92K | -40.57K |